Loading...
XKRX009290
Market cap156mUSD
Dec 24, Last price  
5,650.00KRW
1D
-0.35%
1Q
-3.73%
Jan 2017
-33.33%
Name

Kwangdong Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XKRX:009290 chart
P/E
6.13
P/S
0.15
EPS
922.28
Div Yield, %
1.81%
Shrs. gr., 5y
-0.04%
Rev. gr., 5y
5.11%
Revenues
1.51t
+5.79%
250,523,205,000276,172,800,000276,585,200,000289,434,907,000313,986,322,520332,641,298,450468,384,619,950522,274,344,500955,453,631,8401,056,428,809,4901,141,565,921,0101,180,219,946,7101,238,254,695,8001,243,769,596,2201,338,181,554,3201,431,545,255,1301,514,454,148,123
Net income
36.97b
+52.91%
24,162,480,00021,406,809,00023,185,826,00025,213,710,00029,923,095,00027,823,695,65022,037,369,44035,043,972,22035,015,307,52028,062,800,77023,196,129,92022,345,018,97023,058,315,92045,369,772,62024,019,071,24024,173,930,55036,965,561,780
CFO
-11.73b
L
36,255,245,00016,305,760,00026,275,191,00030,709,004,00027,678,908,97023,738,268,99034,394,125,26032,750,105,08041,143,925,45028,799,301,06023,464,845,77053,096,472,40029,285,287,57022,828,703,29054,939,860,18062,822,034,470-11,730,405,010
Dividend
Dec 27, 2023100 KRW/sh
Earnings
Feb 07, 2025

Profile

Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of antitussive expectorants, ophthalmic, liver disease agents, mineral preparations, vitamins, circulating system, and nutritious tonics; and ETC drugs in the areas of oral hypoglycemic agents, anti-arteriosclerotic agents, metabolic drugs, vitamins, digestive organ agents, circulating systems, immunosuppressants, obesity drugs, urinary genital and anal drugs, appetite suppressants, neuropsychiatric solvents, antispasmodics, antitussive expectorants, anti-vertigo drugs, antivirals agents, anti-malignant-tumor agents, and vasodilator, as well as antiepileptic, antihistaminic, antipyretic, analgesic, and anti-inflammatory agents. The company also provides general supplements, OTC drinks, consumer drinks, functional drinks, and traditional health foods. In addition, it engages in the operation of hospitals; and the retail and wholesale of products through discount stores, TV home shopping, and Internet shopping malls. Further, the company operates as a MRO total service provider for the raw/intermediate materials and consumables under various business models, such as the construction purchase service and overseas local purchase service. Kwang Dong Pharmaceutical Co., Ltd. was founded in 1963 and is based in Seoul, South Korea.
URL
http://www.ekdp.com/
IPO date
Nov 17, 1989
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,514,454,148
5.79%
1,431,545,255
6.98%
1,338,181,554
7.59%
Cost of revenue
1,382,880,387
1,300,090,244
1,209,490,242
Unusual Expense (Income)
NOPBT
131,573,761
131,455,012
128,691,312
NOPBT Margin
8.69%
9.18%
9.62%
Operating Taxes
9,647,574
9,590,017
8,787,940
Tax Rate
7.33%
7.30%
6.83%
NOPAT
121,926,187
121,864,994
119,903,372
Net income
36,965,562
52.91%
24,173,931
0.64%
24,019,071
-47.06%
Dividends
(4,107,878)
(4,107,878)
(4,107,875)
Dividend yield
1.37%
1.68%
1.34%
Proceeds from repurchase of equity
(6,234,892)
BB yield
2.07%
Debt
Debt current
213,949,598
114,368,545
109,114,903
Long-term debt
26,269,342
26,674,568
25,037,925
Deferred revenue
3
1,453,977
Other long-term liabilities
9,343,858
6,098,599
4,003,133
Net debt
(111,113,457)
(56,195,533)
(33,416,473)
Cash flow
Cash from operating activities
(11,730,405)
62,822,034
54,939,860
CAPEX
(35,158,399)
(26,039,379)
(24,447,022)
Cash from investing activities
(71,830,995)
(42,746,565)
(42,975,927)
Cash from financing activities
58,010,422
(628,258)
15,893,760
FCF
(4,381,238)
132,166,442
149,934,428
Balance
Cash
206,181,077
208,632,215
187,700,888
Long term investments
145,151,319
(11,393,569)
(20,131,587)
Excess cash
275,609,689
125,661,383
100,660,224
Stockholders' equity
585,804,559
952,118,156
905,343,363
Invested Capital
557,422,600
557,151,146
553,908,593
ROIC
21.88%
21.94%
22.08%
ROCE
15.75%
19.20%
19.58%
EV
Common stock shares outstanding
40,471
41,081
41,128
Price
7,430.00
24.66%
5,960.00
-19.78%
7,430.00
-27.51%
Market cap
300,698,609
22.81%
244,840,448
-19.88%
305,579,769
-26.44%
EV
233,016,100
218,360,461
300,231,000
EBITDA
144,477,618
145,472,149
142,800,982
EV/EBITDA
1.61
1.50
2.10
Interest
6,903,807
3,735,297
2,543,885
Interest/NOPBT
5.25%
2.84%
1.98%